Navigation Links
BD Board Declares Dividend
Date:7/24/2012

FRANKLIN LAKES, N.J., July 24, 2012 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 45 cents per common share, payable on September 28, 2012 to holders of record on September 7, 2012. The indicated annual dividend rate is $1.80 per share.

About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contacts:
Colleen T. White, Corporate Communications – 201-847-5369;
colleen_white@bd.com

Monique N. Dolecki, Investor Relations – 201-847-5378;
monique_dolecki@bd.com


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
2. Angeion Selects Hendrik Struik for Board of Directors
3. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
4. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
5. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
6. Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend
7. Allscripts Adds Two Independent Directors to Board
8. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
9. Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
10. Generex Augments Antigen Express Scientific Advisory Board
11. Israel Makov Appointed Chairman of Sun Pharma Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/17/2013)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... that it will release its unaudited financial results for the ... May 28, 2013.  The Company will host a conference call ... 28, 2013 at 8:00 p.m. China Standard Time) to review ... corporate developments. To access the conference call, please ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 ... for Science, Technology and Research (A*STAR) and Switzerland,s ... healthy volunteer has been dosed in a Phase 1 clinical ... proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this first ... novel vaccine candidate and its potential to protect against H1N1 ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
(Date:5/18/2013)... May 18, 2013 TheBeautyPlace.com answers important ... hair loss is not a result of stress, nutrient ... Men’s Fitness Magazine, 70% of men suffer from male ... is renowned for hair transplant surgery, but additionally ... pattern baldness known as Bosley Professional Strength. Their product ...
(Date:5/18/2013)... Mobile, AL (PRWEB) May 18, 2013 ... several malignant tumors, the association between obesity and esophageal ... that for other obesity-related tumors. As reported ... obese people are almost twice as likely as those ... disease. Although the relationship between obesity and esophageal cancer ...
(Date:5/18/2013)... Adolescents, especially young males, who experiment with ... are landing in emergency rooms across America. ... with a new treatment program for those addicted ... from the National Institute on Drug Abuse, synthetic marijuana ... teenagers. In 2012, 11 percent of high school seniors ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 Rio ... has recently completed a stylish renovation that features tranquil, ... specialties. , From the ground up, this Morro ... with fresh flooring, soothing colors and comfortable spa beds. ... installed, including an Apilus epilator machine. The shampoo ...
(Date:5/18/2013)... Spectrum Surgical Instruments will attend ... in Austin, TX where thousands of GI nursing ... opportunities. , Spectrum Surgical/STERIS will feature its ... capabilities and certified pre-owned equipment. Attendees will ... proper instrument care of flexible endoscopes. , ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2
... new information on the prevalence of certain gum-disease-causing oral ... of the bacteria with oral bone loss. ... to cause periodontal disease were more likely to have ... oral pathogens. ,Two widely recognized periodontal pathogens, ...
... to results of a 227 patient Phase 2 trial presented ... mg and 180 mg (with background methotrexate) reduces the progression ... human monoclonal antibody which binds to and inhibits the RANK ... formation, function, and survival and thereby plays a key role ...
... current drug surveillance system needs to be fixed, argues an ... follows a recent analysis of the diabetes drug rosiglitazone (Avandia) ... ,Rosiglitazone was approved by the US Food and Drug Administration ... in 2000. Its popularity has increased steadily, with more than ...
... that is a marker for gastric aspiration, are associated with ... researchers in the United Kingdom . This research provides further ... than alloimmunity, the attack the body mounts to protect itself ... taking of stomach fluids into the lung] may contribute to ...
... are considering an overhaul in the process used to ... . ,Last fall, grocers and shoppers were in ... linked to contaminated bagged spinach. Nationwide there were 204 ... deaths. ,The FDA concluded it could not definitively ...
... to the Church of England for featuring a prominent British ... the church said Friday. ,The Japanese firm had ... they had not intended to cause offence by using the ... he added. ,"If we have done so, ...
Cached Medicine News:Health News:Post Menopausal Women are Prone to Gum Disease 2Health News:Denosumab Reduces Bone Erosion 2Health News:Drug Surveillance System Needs to Be Fixed 2Health News:Rejection in Lung Transplants Due to Elevated Pepsin Level 2Health News:FDAs Failure Urges It to Reassess Its Policies 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: